Close [X]
Companies & Industry »Company News»Company News Details
Company News Details

BSE   24 Jan 17 | 04:01 PM

360.00 2.95 (0.83%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   24 Jan 17 | 03:59 PM

359.70 1.85 (0.52%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 349.80 (2.92%)
1 Month : Rs 337.80 (6.57%)
1 Year : Rs 300.80 (19.68%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

Widgets Magazine

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Widgets Magazine

Sensex

Company Price Gain (%)
Bajaj Auto2,800.003.42
M & M1,219.952.68
Adani Ports293.252.41
Coal India309.501.96
Larsen & Toubro1,419.651.88

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine